JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.3
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 16, Issue 1 (2024)
Iran J War Public Health 2024, 16(1): 1001-1010 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2023/12/27 | Accepted: 2024/04/4 | Published: 2024/01/10
Received: 2023/12/27 | Accepted: 2024/04/4 | Published: 2024/01/10
How to cite this article
Sherhan A. Combined Inhalers B-Agonist "Salbutamol" And Steroid Versus Isolated Its Uses In Adults’ Asthmatic Patients.. Iran J War Public Health 2024; 16 (1) :1001-1010
URL: http://ijwph.ir/article-1-1426-en.html
URL: http://ijwph.ir/article-1-1426-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
Ahmed Sherhan *
Ass,professor,department of medicine, Basrah college of medicine , ahmed.sherhan@uobasrah.edu.iq
Abstract (114 Views)
Aims: Inhaled long acting B2-agonist combined with inhaled steroid being longed used in chronic persistent bronchial asthma as a therapy to reduce the needs for admission to hospital and to improve quality of life instead of isolated single uses.
Patients and Method: Two hundred Seven patients with chronic persistent bronchial asthma on variety of inhalers, enrolled randomly in this study, One hundred Twenty (58.0%) were female and Eighty Seven (42.0%) were male, their ages range from sixteen to seventy five with mean ages (45.59±14.67) year's. type of inhalers used, dose, control with a question about admission to hospital, adherence to inhalers ,confidents and recording the parameter of pulmonary function test FEV1, FVC and PEFR while patients on own inhalers type used.
Results:
In this study there are statistically significant different between, single and combined inhalers in chronic persistent asthma (p value0.005)in FEV1LFVC but not between the types of combined inhalers (p.value 0.12 ), age in both types of comparisons indicate no statistically significant effects( p value 0.85,0.47) respectively .
Conclusions: combined inhalers therapy for patients with persistent asthma superior for either alone, preferred and confident by patients; ages of patients neither significantly alter the response nor the patients desire.
Patients and Method: Two hundred Seven patients with chronic persistent bronchial asthma on variety of inhalers, enrolled randomly in this study, One hundred Twenty (58.0%) were female and Eighty Seven (42.0%) were male, their ages range from sixteen to seventy five with mean ages (45.59±14.67) year's. type of inhalers used, dose, control with a question about admission to hospital, adherence to inhalers ,confidents and recording the parameter of pulmonary function test FEV1, FVC and PEFR while patients on own inhalers type used.
Results:
In this study there are statistically significant different between, single and combined inhalers in chronic persistent asthma (p value0.005)in FEV1LFVC but not between the types of combined inhalers (p.value 0.12 ), age in both types of comparisons indicate no statistically significant effects( p value 0.85,0.47) respectively .
Conclusions: combined inhalers therapy for patients with persistent asthma superior for either alone, preferred and confident by patients; ages of patients neither significantly alter the response nor the patients desire.
Send email to the article author